Literature DB >> 2068145

Retinoic acid and alpha-difluoromethylornithine induce different expression of neural-specific cell adhesion molecules in differentiating neuroblastoma cells.

G Melino1, M Piacentini, K Patel, M Annicchiarico-Petruzzelli, L Piredda, J T Kemshead.   

Abstract

Human neuroblastoma cells SK-N-BE(2) can be induced to differentiate towards a neuronal phenotype by retinoic acid (RA) or a schwannian/glial phenotype by alpha-difluoromethylornithine (DFMO), producing differential binding of 14 antibodies (MAbs). RA induced the expression of the neural cell adhesion molecule, NCAM (also confirmed by northern blot); whereas DFMO enhanced the binding of MAbs UJ181.4, UJ127.11 which recognise an identical protein doublet of 220-240 kDa, thought to be the L1 protein(s). The data presented demonstrate that neuroblastoma cells differentiate toward separate phenotypes associated with a specific induction of two different adhesion molecules, NCAM on neuronal cells and L1 on schwannian/glial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068145

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  3 in total

Review 1.  Retinoids and the control of growth/death decisions in human neuroblastoma cell lines.

Authors:  G Melino; C J Thiele; R A Knight; M Piacentini
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Characterisation of a human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones.

Authors:  A Savarese; M Annicchiarico-Petruzzelli; G Citro; G Zupi; L G Spagnoli; A Colantoni; P Vernole; A Stephanou; R A Knight; P Guerrieri
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.

Authors:  G Melino; M Annicchiarico-Petruzzelli; L Piredda; E Candi; V Gentile; P J Davies; M Piacentini
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.